In addition, there is strong evidence of the predictive value of PIK3CA mutations for adjuvant therapy using aspirin, however, further data are needed to definitively define the impact of, especially exon specific, PIK3CA mutation in the management of patients with CRC. Here, PIK3CA is linked to colorectal carcinoma.